Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Zwerling

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of the International AIDS Society|April 7, 2026
Cost-Effectiveness of the I'm Ready HIV Self-Testing Programme Among High-Risk Populations in CanadaLisa Masucci, Hawre Jalal, Sean B Rourke, et al.
Clinical Microbiology Reviews|January 8, 2014
Gamma interferon release assays for detection of Mycobacterium tuberculosis infectionMadhukar Pai, Claudia M Denkinger, Sandra V Kik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 8, 2025
Cost-effectiveness of Targeted Next Generation Sequencing for TB drug-resistance testing as an alternative to the standard of care in South AfricaAlexandra de Nooy, Shaheed Vally Omar, Tom Ockhuisen, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of the International AIDS Society|April 7, 2026
Cost-Effectiveness of the I'm Ready HIV Self-Testing Programme Among High-Risk Populations in CanadaLisa Masucci, Hawre Jalal, Sean B Rourke, et al.
Clinical Microbiology Reviews|January 8, 2014
Gamma interferon release assays for detection of Mycobacterium tuberculosis infectionMadhukar Pai, Claudia M Denkinger, Sandra V Kik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 8, 2025
Cost-effectiveness of Targeted Next Generation Sequencing for TB drug-resistance testing as an alternative to the standard of care in South AfricaAlexandra de Nooy, Shaheed Vally Omar, Tom Ockhuisen, et al.
Pageof 5